Director Declaration

Summary by AI ^BETAClose X

Spire Healthcare Group plc announced that Non-Executive Director Jill Anderson will join the board of Croda International Plc as a Non-Executive Director effective 12 January 2026, also becoming a member of Croda's Audit, Nomination, and Remuneration committees. No further disclosures are required under UKLR 6.4.9R.

Disclaimer*

Spire Healthcare Group PLC

09 January 2026

Spire Healthcare Group plc

Director Declaration

9 January 2026

Spire Healthcare Group plc (LSE: SPI) ('Spire Healthcare', 'the Group' or 'the Company'), a leading independent healthcare group in the UK, announces that Jill Anderson, a Non-Executive Director of the Company, has been appointed as a Non-Executive Director of Croda International Plc. Jill will join the board of Croda International Plc on 12 January 2026 and become a member of the Audit, Nomination and Remuneration committees.

There are no further disclosures required for the purposes of UKLR 6.4.9R.

For further information please contact:

Spire Healthcare Group plc

Amie Gramlick, Director of Commercial Finance & Investor Relations

+44 (0)80 0169 1777

Brunswick (Communications adviser)

Simon Sporborg / Ayesha Bharmal

+44 (0)20 7404 5959

About Spire

Spire is a leading independent healthcare group in the United Kingdom, running 38 hospitals and over 50 clinics, medical centres and consulting rooms across England, Wales and Scotland. It operates a network of private GPs and provides occupational health services to over 800 corporate clients.

Working in partnership with over 8,700 experienced consultants, Spire delivered tailored, personalised care to over one million inpatients, outpatients and daycase patients, and occupational health programme clients, and is the leading private provider, by volume, of knee and hip operations in the United Kingdom. It also delivers a range of private and NHS mental health, musculoskeletal and dermatological services under the Vita Health Group brand.

Spire's well-located and scalable hospitals have delivered successful and award-winning outcomes, positioning the group well with patients, consultants, the NHS, GPs and private medical insurance ('PMI') providers. 98% of Spire's inspected locations are rated 'Good,' 'Outstanding' or the equivalent by health inspectors in England, Wales and Scotland.

Spire is listed on the London Stock Exchange and is a member of the FTSE 250.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END